Title : Nanotechnology for next-generation healthcare: Bridging revolutionized disease diagnosis, precision therapy, and tissue regeneration

Nanotechnology is transforming biomedicine and biomedical engineering by enabling innovative approaches to disease diagnosis, treatment, and regenerative healthcare. Operating at the nanoscale (1–100 nm), engineered nanomaterials possess unique physicochemical and structural properties that facilitate precise interactions with biological systems, supporting the development of personalized and precision medicine.

This work highlights recent advances in three key areas of medical nanotechnology: diagnostics, therapeutics, and regenerative medicine. In diagnostics, nanosensors have significantly improved the early detection of disease biomarkers, enhancing the identification of cancer, cardiovascular, neurodegenerative, and infectious diseases before the onset of clinical symptoms. Their high sensitivity and specificity offer the potential for earlier intervention and improved patient outcomes.

In therapeutics, nanoparticle-based drug delivery systems provide targeted transport of bioactive compounds directly to diseased tissues, increasing therapeutic efficacy while reducing systemic toxicity and adverse effects. Emerging nanorobotic technologies further expand the possibilities for precision medicine by enabling controlled, site-specific therapeutic delivery and minimally invasive interventions.

Nanotechnology also plays a vital role in regenerative medicine through the development of nanostructured biomaterials that mimic the architecture and biological functions of native extracellular matrices. These advanced scaffolds promote cell adhesion, proliferation, and tissue regeneration, supporting functional recovery after injury or disease. Additionally, antimicrobial nanoscale coatings applied to medical devices and healthcare environments represent promising strategies for preventing healthcare-associated infections and improving patient safety.

Despite these remarkable advances, several challenges continue to limit the widespread clinical implementation of nanotechnology. Critical issues include ensuring long-term biocompatibility, understanding nanoparticle toxicity, establishing standardized manufacturing protocols, and addressing regulatory and translational barriers.

Overall, the convergence of nanotechnology with biomedicine and biomedical engineering is driving the development of next-generation healthcare technologies. By integrating advanced diagnostics, targeted therapeutics, and regenerative strategies, nanotechnology has the potential to improve disease management, enhance therapeutic outcomes, and significantly increase patients' quality of life while shaping the future of precision healthcare.

Prof. dr. Mihaela Badea is a professor of biochemistry, laboratory techniques, analytical chemistry, and methodology of scientific research at the Faculty of Medicine, Transilvania University of Brasov, Romania She received the Habilitation in Medicine (2017) from the University of Medicine and Pharmacy Carol Davila in Bucharest. She completed a PhD in Chemistry (2005, Babes-Bolyai University of Cluj-Napoca) and a PhD in Medicine (2021, Transilvania University of Brasov). Since 2019, Dr. Mihaela Badea is a member of the Academic Nutritional Science PhD’s staff of the University of Milan (Italy) and the Coordinator of the Research Center for Fundamental Research and Preventive Strategies in Medicine -Research and Development Institute of the Transilvania University of Brasov.